지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
암 치료성적 향상을 위한 제안
대한의사협회지
2017 .01
Nutrition Therapy to Improve Cancer Treatment Outcome
대한임상종양학회 학술대회지
2017 .02
Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers
Biomolecules & Therapeutics(구 응용약물학회지)
2015 .01
Contradictory Relationships between Cancer and Normal Cells and Implications for Anti-cancer Therapy
Asian Pacific journal of cancer prevention : APJCP
2015 .01
National Cancer Control Plan of the Korea: Current Status and the Fourth Plan (2021-2025)
예방의학회지
2023 .05
Prediction of Cancer Incidence and Mortality in Korea, 2020
Cancer Research and Treatment
2020 .01
Prediction of Cancer Incidence and Mortality in Korea, 2023
Cancer Research and Treatment
2023 .04
Prediction of Cancer Incidence and Mortality in Korea, 2021
Cancer Research and Treatment
2021 .01
Prediction of Cancer Incidence and Mortality in Korea, 2022
Cancer Research and Treatment
2022 .04
Combined Effects of Focused Ultrasound and Photodynamic Treatment for Malignant Brain Tumors Using C6 Glioma Rat Model
Yonsei Medical Journal
2023 .04
Recent developments in cancer therapy and diagnosis
Journal of Pharmaceutical Investigation
2020 .01
Prediction of Cancer Incidence and Mortality in Korea, 2019
Cancer Research and Treatment
2019 .01
Prediction of Cancer Incidence and Mortality in Korea, 2017
Cancer Research and Treatment
2017 .01
한국의 암환자 치료와 관리현황
대한의사협회지
2017 .01
Prediction of Cancer Incidence and Mortality in Korea, 2016
Cancer Research and Treatment
2016 .01
Spontaneously Diabetic Torii (SDT) rat and SDT fatty rat : New Animal Models of Type 2 Diabetes - with Severe Diabetic Complications
한국실험동물학회 학술발표대회 논문집
2015 .08
Cancer research using molecular imaging
한국실험동물학회 학술발표대회 논문집
2021 .07
Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer
Investigative and Clinical Urology
2022 .03
0